M&A Deal Summary

AAC Capital Nordic Advisory AB, Capital A and Intermediate Capital Group Acquire Loparex Group

On September 1, 2005, private equity firm AAC Capital Nordic Advisory AB, private equity firm Capital A and mezzanine finance firm Intermediate Capital Group acquired manufacturer Loparex Group for 230M EUR

Acquisition Highlights
  • This is AAC Capital Nordic Advisory AB’s 1st, Capital A’s 3rd and Intermediate Capital Group’s 8th transaction in the Manufacturing sector.
  • This is AAC Capital Nordic Advisory AB’s , Capital A’s 2nd and Intermediate Capital Group’s 56th largest (disclosed) transaction.
  • This is AAC Capital Nordic Advisory AB’s 1st, Capital A’s 16th and Intermediate Capital Group’s 7th transaction in the Netherlands.

M&A Deal Summary

Date 2005-09-01
Target Loparex Group
Sector Manufacturing
Buyer(s) AAC Capital Nordic Advisory AB
Capital A
Intermediate Capital Group
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 230M EUR

Target

Loparex Group

Apeldoorn, Netherlands
Loparex Group is a manufacturer of polycoated and silicone-coated papers and films, used in a wide variety of pressure sensitive adhesive applications. With in-depth technical expertise, state-of-the-art production technology and flexible service programs around the world, Loparex can offer you the right release liner for your specific application.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 3

DESCRIPTION

AAC Capital Nordic Advisory AB is a North European private equity firm focused on acquiring majority stakes in mid-market companies in the Nordic countries. It seeks to invest in companies with an enterprise value up to €150 million. AAC Capital Nordic Advisory was formerly known as ABN Amro Capital and became independent of ABN Amro in 2007. AAC Capital Nordic is a private equity arm of AAC Capital partners was formed in 2010 and is based in Stockholm.


DEAL STATS #
Overall 4 of 9
Sector (Manufacturing) 1 of 2
Type (Buyout (LBO, MBO, MBI)) 3 of 6
Country (Netherlands) 1 of 1
Year (2005) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-06-14 Handicare Group AB

Stockholm, Sweden

Formed in 1986, Handicare offers solutions to increase the independence of disabled or elderly people and to facilitate for their care providers and family. The offering encompasses a comprehensive range of curved and straight stairlifts, transfer, lifting, and repositioning aids and vehicle adaptations. Handicare is a global company with sales in some 40 countries and is one of the market leaders in this field. Its head office is in Stockholm, Sweden, and manufacturing and assembly are located at four sites distributed across North America, Asia, and Europe.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-29 Fiskars Home Oy Ab

Helsinki, Finland

iittala is a manufacturer and marketer of premium branded home ware based on Scandinavian design.

Sell €235M
Buyer

Capital A

Amsterdam, Netherlands

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1985
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Capital A Investment Partners is a private equity firm specializing in management buyouts, management buy-ins, expansion/growth financing, shareholder replacement, and turnarounds. Capital A Investment Partners targets mid-sized Dutch companies invest in mature companies with positive and consistent cash generation that belong to the top of their sector. Capital A Investment Partners invest across all sectors. The Firm typically invests in a broad range of industry sectors with an investment of €5 - €50 million per transaction.


DEAL STATS #
Overall 21 of 72
Sector (Manufacturing) 3 of 7
Type (Buyout (LBO, MBO, MBI)) 13 of 40
Country (Netherlands) 16 of 60
Year (2005) 4 of 4
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-07-19 GlycArt Biotechnology AG

Zurich, Switzerland

GlycArt is a Swiss biotechnology company focussed on the development and commercialisation of a new generation of antibody products based on its proprietary GlycoMAb technology. GlycArt has generated its own GlycoMAb-based antibody portfolio by in-licensing and acquiring antibodies at early stages of development and applying GlycoMAb to them.

Sell Fr.235M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-11-01 Starsweets Holland BV

Breda, Netherlands

Distribution of sweets.

Sell -
Buyer

Intermediate Capital Group

London, United Kingdom

Investor Investor Investor Investor Investor


Category Mezzanine Finance Firm
Founded 1989
PE ASSETS 74.5B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Intermediate Capital Group (ICG) is a global mezzanine finance firm. IGC looks to provide junior capital to support a wide range of transactions, including buyouts, debt restructurings, and development financing. The Firm generally invests alongside financial sponsors and management teams in transactions valued from €250 million to €1 billion. ICG was formed in 1989 and is headquartered in London.


DEAL STATS #
Overall 142 of 292
Sector (Manufacturing) 8 of 12
Type (Buyout (LBO, MBO, MBI)) 86 of 112
Country (Netherlands) 7 of 12
Year (2005) 21 of 29
Size (of disclosed) 56 of 82
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-09-01 Famosa

Alicante, Spain

Famosa designs, develops, manufactures and distributes toys throughout the world. The company owns and has developed several well known and successful brands including Nenuco, Barriguitas, Nancy, Jaggets, Pin y Pon and Feber. Famosa also has licensing agreements to develop, manufacture and design toys with some of the world’s largest entertainment and sports companies.

Sell €130M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-09-16 PHS Group

Caerphilly, United Kingdom

PHS Group Plc provides washroom services (cleaning and maintenance) to customers across the UK.

Buy £730M